Sen. Risa Hontiveros stressed that the private individuals involved in the anomalous Php11.5-billion peso Pharmally deal should be held accountable following the recommendations of the Senate Blue Ribbon committee then led by Senator Gordon
Sen. Leila De Lima said Friday that she is displeased with some senators in the Blue Ribbon Committee who did not sign the draft report of the Senate s investigations on the questionable transactions of Pharmally Pharmaceutical Corp. with the government.
After months of investigation, the Senate Blue Ribbon committee report on the Pharmally supply deal lacked two signatures for plenary approval of the findings and recommendations. With the chamber adjourning sine die this week, however, plenary approval may no longer be possible within the current Congress.